Literature DB >> 18622136

Relationship between lipoprotein(a), metabolic syndrome, and carotid atherosclerosis in older Japanese people.

Kazuhiko Kotani1, Hisashi Shimohiro, Seiji Adachi, Naoki Sakane.   

Abstract

BACKGROUND: Lipoprotein(a) [Lp(a)] or metabolic syndrome (MS) is individually considered an atherosclerotic factor. Serum Lp(a) may reportedly show the additive effects on atherosclerosis under certain particular pathologies. We do not know the association between serum Lp(a) and carotid artery intima-media thickness (CIMT) with relation to MS in older people.
OBJECTIVE: The present study aims at investigating the relationship between Lp(a) and CIMT levels in relation to MS among older subjects.
METHODS: We studied 182 Japanese subjects of >or=60 years (mean 72.5 years), free of cardiovascular/cerebrovascular disease. MS was based on the NCEP-ATPIII criteria with a minor modification for Japanese. The CIMT was ultrasonographically measured.
RESULTS: The CIMT levels were significantly greater in the MS group (n = 60, 1.03 +/- 0.22 mm) than the non-MS group (n = 122, 0.96 +/- 0.22 mm). Multivariate analysis, using Lp(a) levels or the product term for interaction between Lp(a) and MS, showed that age significantly and independently correlated to CIMT, along with male gender. DISCUSSION: Even when Lp(a) and MS were simultaneously considered, age was the best determinant of CIMT in this population. The mechanism of our results including weak additive effects of Lp(a) and MS among older subjects may be partly throughout aging. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622136     DOI: 10.1159/000145541

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  5 in total

1.  Lipoprotein(a) and inhibitors of proprotein convertase subtilisin/kexin type 9.

Authors:  Kazuhiko Kotani; Maciej Banach
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

2.  Lipoprotein(a) Change After Sleeve Gastrectomy Is Affected by the Presence of Metabolic Syndrome.

Authors:  Silvia Paredes; Marta Alves; Maria Lopes Pereira; Olinda Marques; Laura Ribeiro
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

3.  The association between reactive oxygen metabolites and metabolic syndrome in asymptomatic Japanese men.

Authors:  Kazuhiko Kotani; Nobuyuki Taniguchi
Journal:  J Clin Med Res       Date:  2011-09-26

4.  Carotid intima-media thickness and plasma fibrinogen among subjects with metabolic syndrome: Isfahan cohort study, Iran.

Authors:  Zahra Bayanfar; Masoumeh Sadeghi; Ramin Heidari; Mojgan Gharipour; Mohammad Talaie; Akram Sedaghat
Journal:  ARYA Atheroscler       Date:  2014-09

5.  Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence Study.

Authors:  Valmore Bermúdez; Joselyn Rojas; Juan Salazar; Luis Bello; Roberto Añez; Alexandra Toledo; Maricarmen Chacín; Miguel Aguirre; Marjorie Villalobos; Mervin Chávez; María Sofía Martínez; Wheeler Torres; Yaquelin Torres; José Mejías; Edgardo Mengual; Liliana Rojas; Milagro Sánchez de Rosales; Ana Quevedo; Raquel Cano; Mayela Cabrera; Rafael París; Adonías Lubo; María Montiel; Climaco Cano
Journal:  J Diabetes Res       Date:  2013-04-22       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.